PVP Ventures (PVP) share price, P/E, ROE & financials

PVP Ventures (PVP) had a P/E of 220.5× on 6 Nov 2026, above the industry P/E of 14.8×, and the shares are 39% below their 52-week high. It earns ROCE of 3.9% and ROE of −3.1%, and sales fell 20% a year over 3 years. Debt is 0.65× equity. It is a small-cap company with a market cap of ₹1,148 Cr, ranked 20th of 52 Conglomerates companies by market cap; the shares rose 38% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year

Open: ₹45.99
Day high: ₹45.99
Day low: ₹43.80
Prev. close: ₹45.02
Volume: 3 L

Health check

1 good · 5 to check

ReturnsAhead
+37.5% over a year, better than 7 of 7 peers.
Price tagPricier
P/E 220.5 vs industry 14.8.
GrowthShrinking
Sales −20.1% a year over 3 years.
ProfitabilityWeak
ROCE 3.9% vs peer median 12.8%.
Balance sheetStretched
Debt 0.65× equity, interest covered 0.7×.
Red flags4 to check
Return on equity is low at −3.1%.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Conglomerates

51 listed peers. Screen the industry

Small cap

₹1,148 Cr, #20 of 52 in its industry by size.

Defensive

Beta 0.74 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹118 Cr · profit ₹5 Cr

Market cap: ₹1,148 Cr; Small cap
P/E: 220.5; Industry 14.8
Price to book: 5.26; Peers 5.18
Dividend yield: 0.00%
ROE: −3.1%; Peers 11.6%
ROCE: 3.9%; Peers 12.8%
Debt to equity: 0.65; Debt ₹257 Cr
EPS (TTM): ₹0.20; Face value ₹10
OPM (TTM): 23.6%; Net margin 4.2%
Sales growth: +165.2%; Latest quarter vs a year ago
Profit growth: +4086.5%; Latest quarter vs a year ago
Price to sales: 9.72; EV/EBITDA 63.3

Strengths

Quarterly profit up 4086.5% on a year ago.
Quarterly sales up 165.2% on a year ago.

Risks to check

Return on equity is low at −3.1%.
P/E of 220.5 against an industry P/E of 14.8.
39% below its 52-week high.
Interest coverage of only 0.7×.

Derived automatically from reported figures. Not a recommendation.

About PVP Ventures

Evervie Health Limited provides healthcare services in India. The company operates a hospital-partnered dialysis network for renal care, including participation in government dialysis programs. It also operates radiation-led comprehensive cancer care centers that provide cancer treatment services in markets outside metropolitan areas. Additionally, the company operates a hub-and-spoke diagnostics platform that provides screening and early detection…

Headquarters: Hyderabad
Employees: 20
Sector: Industrials
ISIN: INE362A01016
Website: everviehealth.com

Price range

52 weeks

₹23.00₹72.04

Today

₹43.80₹45.99

Avg volume (3M): 20.3 L
1-year return: plus 37.5%
From 52-week high: minus 38.8%

Peers · Conglomerates

Capital-heavy industry columns

Compare with peers Screen the whole industry

Company
SRFSRF	2,460.40	minus 0.99%	72,928	31.9	21.2	14.5%	24.2%	0.35	1.8%	minus 15.5%
TIINDIATube Investments of India	2,170.00	minus 5.65%	42,005	62.9	16.6	12.8%	9.9%	0.05	15.5%	minus 23.1%
GODREJINDGodrej Industries	955.85	minus 2.40%	32,198	27.4	32.4	12.3%	10.4%	2.22	9.8%	minus 11.6%
3MINDIA3M India	27,570.00	minus 5.98%	31,058	57.0	29.9	47.5%	18.4%	0.10	8.7%	minus 18.3%
THERMAXThermax	2,746.30	minus 17.27%	30,937	52.6	26.6	15.3%	12.4%	0.42	9.8%	plus 1.5%
BEMLBEML	1,953.20	minus 1.89%	16,268	28.0	55.7	5.9%	7.3%	0.11	3.0%	minus 7.4%
NAVANava	529.15	minus 0.99%	14,991	19.8	7.9	11.1%	38.4%	0.21	6.8%	minus 12.1%
PVPPVP Ventures	44.10	minus 2.04%	1,148	220.5	68.9	–	15.7%	0.65	−20.1%	plus 37.5%
Median of 7 peers	–	−2.40%	31,058	31.9	26.6	12.8%	12.4%	0.21	8.7%	−12.1%

Quarterly results

Consolidated, ₹ crore

SalesSelect a row below to chart it

Jun 25	Sep 25	Dec 25	Mar 26	Jun 26
17.2	17.1	14	41.4	45.6
12.2	14.7	9	34.2	32.3
5.1	2.4	5	7.2	13.3
29.3%	14.0%	35.8%	17.4%	29.1%
3.7	3.9	2	12.5	25.8
8.3	8.4	7.5	9.3	10.1
1	1.4	1.4	9.9	6.1
–	–	–	−3.1	−10.9
−0.5	−3.6	−1.9	−2.5	12
77.0%	27.3%	−119.1%	−27.9%	7.8%
0.3	−3.2	−3.5	−0.4	12.1
0.01	-0.12	-0.14	–	0.46

Profit & loss

Yearly, ₹ crore

Sales CAGR 3Y: −20.1%
ROE: −3.1%

Net profitSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
176	8.5	27.2	89.7
–	minus 95.2%	+221.1%	+229.8%
46.3	17.6	34.5	67.1
129	−9.2	−7.3	22.6
73.7%	−108.2%	−26.9%	25.2%
0.2	5.1	4.5	13.6
10.1	5.4	4	33.5
1.1	1.9	2	13.7
144	72.9	−0.1	2.5
263	61.6	−8.9	−8.5
9.4%	−8.1%	3.3%	−17.7%
144	67	−6.7	−6.8
–	minus 53.4%	minus 110.0%	–
5.87	2.64	-0.26	-0.26

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
244	260	260	260
−95.9	−30.9	−38.4	−42.2
119	43.2	23.3	257
71.4	106	130	308
339	379	375	783
3.9	8.4	6.5	101
–	1.8	–	0.3
4.7	3	2.2	5.9
8.4	5.5	0.6	51.3
322	361	366	625
339	379	375	783

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
327	0	19.5	−23.5
−123	6.4	2.8	−153
−203	−7.8	−22.5	189
1.4	−1.4	−0.1	13.3
–	−2.2	−0.7	−28.2
327	−2.2	18.8	−51.6

Shareholding pattern

Source: NSE filings

61.3%

promoters

Promoters61.30%
Public38.70%
As of 30 Sep 2026

Quarter	Promoters	Public	Promoter change
30 Sep 2026	61.30%	38.70%	0.00
30 Jun 2026	61.30%	38.70%	0.00
31 Mar 2026	61.30%	38.70%	0.00
31 Dec 2025	61.30%	38.70%	0.00
30 Sep 2025	61.30%	38.70%	–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you